The stock will trade on the outcome of the July 23 shareholder vote and subsequent Stage 1 closing. If approved, the value of FRSX shares will be heavily tied to VWAV's stock price and the strategic collaboration's success. Monitor VWAV price action and any proxy advisory recommendations ahead of the vote.
Price Chart
Executive Summary
Foresight Autonomous Holdings (FRSX) filed a proxy statement for an Annual and Extraordinary General Meeting on July 23, 2026, seeking shareholder approval for a transformative Securities Exchange Agreement with VisionWave Holdings (VWAV). Under the two-stage deal, VisionWave will ultimately own 52% of FRSX in exchange for VWAV common stock valued at $17.5 million total ($15.48M at Stage 1, $2.02M at Stage 2), with a value protection mechanism guaranteeing 65% of the consideration. The transaction implies a significant premium to FRSX's $4M market cap and would give FRSX a substantial publicly traded asset, but existing shareholders face heavy dilution to 48% ownership.
Key Facts
- VisionWave to receive 46% of FRSX at Stage 1, plus 6% at Stage 2 upon milestone achievement, for a total 52% ownership
- FRSX to receive VWAV shares worth $15,480,769 at Stage 1 and $2,019,231 at Stage 2, aggregate $17.5 million
- Value protection mechanism guarantees 65% of each stage's consideration ($10,062,500 Stage 1, $1,312,500 Stage 2)
- Stage 1 closing to occur 45–120 days after June 3, 2026 effective date, subject to shareholder and regulatory approvals
- Shareholder meeting scheduled for July 23, 2026; record date July 6, 2026
- Board unanimously recommends voting FOR all proposals, including the VisionWave Transaction
Financial Impact
FRSX receives VWAV stock valued at $17.5 million (over 4x its $4M market cap) but issues 52% of its equity, implying a post-deal valuation of ~$33.6M. Value protection covers 65% of consideration.
Risk Factors
- Shareholder vote fails to approve the VisionWave Transaction
- VWAV stock price declines, reducing the value of consideration received
- Milestone for Stage 2 not achieved, limiting total consideration to $15.48M
- Regulatory or Nasdaq approval delays or denials
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001493152-26-028678 |
| Document: form6-k.htm | 0001493152-26-028678 |
| Document: 0001493152-26-028678-index-headers.html | 0001493152-26-028678 |
| Document: 0001493152-26-028678-index.html | 0001493152-26-028678 |
| Document: 0001493152-26-028678.txt | 0001493152-26-028678 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 7w ago | Press Release | $1.19 $1.05 | ▲ +11.79% | ▲ +9.82% | $1.12 (+5.91%) |
Jul 27, 2026 9w ago | 6-K | $1.35 $1.17 | ▼ −13.33% | ▼ −16.63% | $1.12 (−17.04%) |
Jun 15, 2026 15w ago | 6-K | $1.57 $1.39 | ▼ −11.46% | ▼ −11.66% | $1.12 (−28.66%) |
Jun 8, 2026 16w ago | 6-K | $1.40 $1.83 | ▲ +30.71% | ▲ +29.08% | $1.12 (−20.00%) |
May 5, 2026 21w ago | Press Release | $2.02 $1.91 | ▼ −5.45% | ▼ −10.40% | $1.12 (−44.55%) |
Apr 29, 2026 22w ago | 6-K | $2.09 $2.00 | ▼ −4.31% | ▼ −9.77% | $1.12 (−46.41%) |
Apr 24, 2026 23w ago | 6-K | $2.00 $2.01 | ▲ +0.50% | ▼ −3.53% | $1.12 (−44.00%) |
Mar 26, 2026 27w ago | 6-K | $2.40 $2.01 | ▲ +16.25% | ▲ +28.99% | $1.12 (+53.33%) |
Mar 13, 2026 29w ago | Press Release | $2.05 $2.32 | ▲ +13.17% | ▲ +9.58% | $1.12 (−45.37%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access